Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters

Functional Neurology

Volumn 20, Issue 3, 2005, Pages 127-130

  Roth, Jan ^a   Klempíř, Jiří ^a   Jech, Robert ^a   Židovská, Jana ^a   Uhrová, Tereza ^a   Doubek, Pavel ^a   Ulmanová, Olga ^a   Brožová, Hana ^a   Volfová, Markéta ^a   Serranová, Tereza ^a   Růžička, Evžen ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

CAG triplet; Caudate nucleus; Computed tomography; Huntington's disease; Neuroimaging

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; CAUDATE NUCLEUS; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; EXTRACHROMOSOMAL INHERITANCE; FEMALE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; ONSET AGE; STATISTICAL SIGNIFICANCE;

ADULT; AGING; ATROPHY; CAUDATE NUCLEUS; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; ORGAN SIZE; REFERENCE VALUES; STATISTICS, NONPARAMETRIC;

EID: 30644463604     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease chromosomes. Cell 1993;72:971-983
2. DiFiglia M, Sapp E, Chase KO et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997;277:1990-1993
3. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577
4. Lange H, Thorner G, Hopf A, Schroder KF. Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci 1976;28:401-425
5. de la Monte SM, Vonsattel JP, Richardson EP Jr. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988;47:516-525.
6. Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, McCusker E. Regional specificity of brain atrophy in Huntington's disease. Exp Neurol 1998;154:663-672
7. Gomori JM, Steiner I, Melamed E, Cooper G. The assessment of changes in brain volume using combined linear measurement. A CT-scan study. Neuroradiology 1984;26:21-24
8. Roth J, Havrdova E, Stikova V, Bauer J. The CT image of atrophy of the head of the caudate nucleus in Huntington's chorea. Cas Lek Ces 1996;135:277-279
9. Sharma P, Savy L, Britton J, Taylor R, Howick A, Patton M. Huntington's disease: a molecular genetic and CT comparison. J Neurol Neurosurg Psychiatry 1996;60:206-208
10. Culjkovic B, Stojkovic O, Vojvodic A et al. Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington's disease. J Neurol 1999;246:1090-1093
11. Wardlaw JM, Sellar RJ, Abernethy LJ. Measurement of caudate nucleus area - a more accurate measurement for Huntington's disease? Neuroradiology 1991;33:316-319
12. Roth J, Havrdova E, Ruzicka E. Atrophy of caudate nucleus in Huntington's disease measured by means of computed tomography. J Neurol 2000;247:880-881
13. Aylward EH, Codori AM, Barta PE, Pearlson GD, Harris GJ, Brandt J. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch Neurol 1996;53:1293-1296
14. Aylward EH, Li Q, Stine OC et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 1997;48:394-399
15. Aylward EH, Codori AM, Rosenblatt A et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord 2000; 15:552-560
16. Hardie RJ, Pullon HW, Harding AE et al. Neuroacanthocytosis: a clinical, haematological and pathological study of 19 cases. Brain 1991;114:13-49
17. Kambouris M, Bohlega S, Al-Tahan A, Meyer BF. Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3. Am J Hum Genet 2000;66:445-452
18. Klockgether T, Skalej M, Wedekind D et al. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain 1998;121:1687-1693
19. Snell RG, MacMillan JC, Cheadle JP et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet 1993;4:393-397
20. Claes S, Van Zand K, Legius E et al. Correlations between triplet repeat expansion and clinical features in Huntington's disease. Arch Neurol 1995;52:749-753
21. Rosenblatt A, Brinkman RR, Liang KY et al. Familial influence on age of onset among siblings with Huntington disease. Am J Med Genet 2001;105:399-403
22. Li JL, Hayden MR, Almqvist EW et al. A genome scan for modifiers of age at onset in Huntington disease. The HD MAPS study. Am J Hum Genet 2003;73:682-687
23. Brinkman RR, Mezei MM, Theilmann J, Almqvist E, Hayden MR. The likehood of being affected with Huntington's disease by a particular age, for a specific CAG size. Am J Hum Genet 1997;60:1202-1210
24. Trottier Y, Biancalana V, Mandel JL. Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J Med Genet 1994;31:377-382
25. Kovtun IV, Welch G, Guthrie HD, Hafner KL, McMurray CT. CAG repeat lengths in X- and Y-bearing sperm indicate that gender bias during transmission of Huntington's disease gene is determined in the embryo. J Biol Chem 2004; 279:9389-9391